Your browser doesn't support javascript.
loading
Effect of Acridine Orange and Zoledronic Acid on Bone Metastasis in Renal Cell Carcinoma.
Oya, Keita; Tsuchie, Hiroyuki; Nagasawa, Hiroyuki; Hongo, Michio; Kasukawa, Yuji; Kudo, Daisuke; Shoji, Ryo; Kasama, Fumihito; Kawaragi, Takashi; Watanabe, Manabu; Tominaga, Kenta; Miyakoshi, Naohisa.
Afiliación
  • Oya K; Department of Orthopedic Surgery, Akita University Graduate School of Medicine, Akita, Japan; koya@med.akita-u.ac.jp.
  • Tsuchie H; Department of Orthopedic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
  • Nagasawa H; Department of Orthopedic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
  • Hongo M; Department of Orthopedic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
  • Kasukawa Y; Department of Orthopedic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
  • Kudo D; Department of Orthopedic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
  • Shoji R; Department of Orthopedic Surgery, Akita Kousei Medical Center, Akita, Japan.
  • Kasama F; Department of Orthopedic Surgery, Yuri Kumiai General Hospital, Akita, Japan.
  • Kawaragi T; Department of Orthopedic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
  • Watanabe M; Department of Orthopedic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
  • Tominaga K; Department of Orthopedic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
  • Miyakoshi N; Department of Orthopedic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
Anticancer Res ; 44(6): 2487-2495, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38821618
ABSTRACT
BACKGROUND/

AIM:

The increasing incidence of renal cell carcinoma (RCC) and its associated bone metastasis pose challenges in surgical interventions, warranting the exploration of novel therapeutic approaches. Therefore, this study aimed to assess the impact of hematogenously administering acridine orange (AO) alone and in combination with zoledronic acid (ZA) on bone metastasis in RCC. MATERIALS AND

METHODS:

RENCA cells (1.0×106 cells/10 µl) were directly injected into the right femur of male BALB/c mice. The mice were categorized into four groups based on the applied therapeutic intervention and were euthanized after five weeks. Micro-computed tomography was performed to quantify the extent of periosteal reaction, indicative of bone metastasis, along the entire length of the femur. Tumor weight and volume were measured at euthanization. Hematoxylin and eosin staining was used to examine the extent of tumor development in the bone. Apoptotic cell, osteoclast, and vascular endothelial growth factor (VEGF)-positive cell counts were assessed using TdT-mediated dUTP-biotin nick end labeling, tartrate-resistant acid phosphatase staining, and VEGF staining, respectively.

RESULTS:

The periosteal reaction was significantly reduced in the intervention groups compared to the control group (p<0.05). The apoptotic cell numbers in the intervention groups surpassed that in the control group (p<0.05), whereas those of osteoclasts and VEGF-positive cells in the intervention groups were lower than those in the control group (p<0.05).

CONCLUSION:

AO hinders bone metastasis progression in RCC, and combination therapy with ZA may be more effective than AO administration alone.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Naranja de Acridina / Neoplasias Óseas / Carcinoma de Células Renales / Apoptosis / Ácido Zoledrónico / Neoplasias Renales / Ratones Endogámicos BALB C Límite: Animals / Humans / Male Idioma: En Revista: Anticancer Res Año: 2024 Tipo del documento: Article Pais de publicación: Grecia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Naranja de Acridina / Neoplasias Óseas / Carcinoma de Células Renales / Apoptosis / Ácido Zoledrónico / Neoplasias Renales / Ratones Endogámicos BALB C Límite: Animals / Humans / Male Idioma: En Revista: Anticancer Res Año: 2024 Tipo del documento: Article Pais de publicación: Grecia